Form 4: Shattuck Labs CFO Acquires Options, Disposes Shares

Shattuck Labs' Chief Financial Officer, Andrew R. Neill, reported the acquisition of 549,800 stock options and the disposition of 6,660 common shares for tax purposes.

Summary

• Andrew R. Neill, Chief Financial Officer of Shattuck Labs, Inc., acquired 549,800 stock options with an exercise price of $4.75 per share.
• These options have a vesting schedule: one-quarter will vest on January 10, 2027, with the remaining three-quarters vesting in equal monthly installments through January 10, 2030, subject to continued service.
• The acquired stock options have an expiration date of January 10, 2036.
• Neill also disposed of 6,660 shares of common stock at a price of $4.75 per share to cover tax liabilities incident to the vesting of a restricted stock award or the exercise of a stock option.
• Following these transactions, Neill directly owns 230,813 shares of common stock and 549,800 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The filing indicates a routine executive compensation event with a significant option grant, which is generally positive for aligning management interests, balanced by a small tax-related share disposition.

Positives

• The Chief Financial Officer received a significant grant of 549,800 stock options, which aligns his long-term interests with shareholder value creation.
• The stock options have a 10-year expiration date, providing a substantial window for potential value realization.

Negatives

• The disposition of 6,660 shares, while for tax purposes, represents a reduction in the CFO's direct common stock holdings.

Future Outlook

The filing details a long-term incentive structure for the CFO through stock options with a vesting schedule extending to January 2030, contingent on continued service.

Industry Context

This is a routine insider transaction report reflecting standard equity compensation practices for executives, common across various industries, including biotechnology.

Related Party Transactions

• The transactions involve the company's Chief Financial Officer, Andrew R. Neill, receiving equity compensation and disposing of shares for tax purposes, which are standard related-party dealings in the context of executive compensation.

Stakeholder Impact

• Shareholders: The grant of stock options to the CFO aligns his long-term interests with shareholder value creation, potentially incentivizing performance. The tax-related disposition is a minor, routine event.
• Employees: No direct impact on other employees is mentioned.

Next Steps

• Continued service of Andrew R. Neill to the Issuer for the stock options to vest.
• Vesting of one-quarter of the stock options on January 10, 2027.
• Monthly vesting of the remaining three-quarters of stock options through January 10, 2030.

Key Dates

Recommendation

This Form 4 details a routine executive compensation event, including a significant stock option grant and a tax-related share disposition. While the option grant aligns the CFO's interests with long-term company performance, it does not provide new fundamental information about the company's operational or financial health to warrant a change in investment stance. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing company fundamentals.

Keywords

Shattuck Labs, STTK, Form 4, Insider Trading, Stock Options, CFO, Equity Compensation, Beneficial Ownership, Andrew R. Neill